Search results
Results from the WOW.Com Content Network
This page was last edited on 8 December 2023, at 18:09 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
Pimobendan is indicated for the management of the signs of mild, moderate, or severe congestive heart failure in dogs due to clinical myxomatous mitral valve disease (MMVD) or dilated cardiomyopathy (DCM); [1] [7] and for use with concurrent therapy for congestive heart failure (e.g.,furosemide, etc.) as appropriate on a case-by-case basis. [1]
The journal was established in 1987 by the American College of Veterinary Internal Medicine with approval of the American Veterinary Medical Association. [1] It was published as a bi-monthly, print journal until 2014, and became an open access journal as of January 1, 2015. [1]
Consensus statements differ from medical guidelines, another form of state-of-the-science public statements. According to the NIH, "Consensus statements synthesize new information, largely from recent or ongoing medical research , that has implications for reevaluation of routine medical practices.
Diabetes in cats can be classified into the following: Type 1 diabetes, in which the immune system attacks the pancreas, is "extremely rare" in cats, unlike in dogs and humans. [2] Type 2 diabetes is responsible for 80–95% of diabetic cases. They are generally severely insulin dependent by the time symptoms are diagnosed.
The main goal of diabetes management is to keep blood glucose (BG) levels as normal as possible. [1] If diabetes is not well controlled, further challenges to health may occur. [1] People with diabetes can measure blood sugar by various methods, such as with a BG meter or a continuous glucose monitor, which monitors over several days. [2]
varied by: 1) provision of general calorie recommendations, 2) provision of specific calorie information, and 3) whether high- or low-calorie items were more easily accessible. Results suggest that a strictly informational approach may be less effective than subtle guidance in enticing fast-food customers towards healthier meals.
The 2022 American Diabetes Association (ADA) standards of medical care in diabetes include SGLT2 inhibitors as a first line pharmacological therapy for type 2 diabetes (usually together with metformin), specifically in patients with chronic kidney disease, cardiovascular disease or heart failure.